nodes	percent_of_prediction	percent_of_DWPC	metapath
Iloperidone—Menstruation irregular—Levothyroxine—hypothyroidism	0.0272	0.0485	CcSEcCtD
Iloperidone—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.0272	0.0485	CcSEcCtD
Iloperidone—Menstruation irregular—Liotrix—hypothyroidism	0.02	0.0357	CcSEcCtD
Iloperidone—HTR2A—cerebellar cortex—hypothyroidism	0.0189	0.0525	CbGeAlD
Iloperidone—DRD1—nerve—hypothyroidism	0.0178	0.0494	CbGeAlD
Iloperidone—Arrhythmia—Liothyronine—hypothyroidism	0.0137	0.0245	CcSEcCtD
Iloperidone—DRD4—heart—hypothyroidism	0.0131	0.0364	CbGeAlD
Iloperidone—CYP1A2—urine—hypothyroidism	0.0128	0.0356	CbGeAlD
Iloperidone—Increased appetite—Levothyroxine—hypothyroidism	0.0116	0.0207	CcSEcCtD
Iloperidone—Increased appetite—Dextrothyroxine—hypothyroidism	0.0116	0.0207	CcSEcCtD
Iloperidone—CYP2E1—urine—hypothyroidism	0.0115	0.0321	CbGeAlD
Iloperidone—Cardiac failure—Levothyroxine—hypothyroidism	0.0112	0.02	CcSEcCtD
Iloperidone—Cardiac failure—Dextrothyroxine—hypothyroidism	0.0112	0.02	CcSEcCtD
Iloperidone—HTR7—nerve—hypothyroidism	0.0111	0.0308	CbGeAlD
Iloperidone—Affect lability—Levothyroxine—hypothyroidism	0.0107	0.0192	CcSEcCtD
Iloperidone—Affect lability—Dextrothyroxine—hypothyroidism	0.0107	0.0192	CcSEcCtD
Iloperidone—Tachycardia—Liothyronine—hypothyroidism	0.0107	0.019	CcSEcCtD
Iloperidone—Fluid retention—Liotrix—hypothyroidism	0.0105	0.0187	CcSEcCtD
Iloperidone—DRD2—nerve—hypothyroidism	0.0105	0.0292	CbGeAlD
Iloperidone—Mood swings—Levothyroxine—hypothyroidism	0.0103	0.0185	CcSEcCtD
Iloperidone—Mood swings—Dextrothyroxine—hypothyroidism	0.0103	0.0185	CcSEcCtD
Iloperidone—Hypotension—Liothyronine—hypothyroidism	0.0102	0.0182	CcSEcCtD
Iloperidone—Dehydration—Levothyroxine—hypothyroidism	0.0102	0.0181	CcSEcCtD
Iloperidone—Dehydration—Dextrothyroxine—hypothyroidism	0.0102	0.0181	CcSEcCtD
Iloperidone—HTR2A—urine—hypothyroidism	0.01	0.0279	CbGeAlD
Iloperidone—CYP3A4—urine—hypothyroidism	0.00928	0.0258	CbGeAlD
Iloperidone—CYP2D6—urine—hypothyroidism	0.00913	0.0254	CbGeAlD
Iloperidone—Renal failure acute—Liotrix—hypothyroidism	0.0087	0.0155	CcSEcCtD
Iloperidone—Body temperature increased—Liothyronine—hypothyroidism	0.00864	0.0154	CcSEcCtD
Iloperidone—Increased appetite—Liotrix—hypothyroidism	0.00855	0.0153	CcSEcCtD
Iloperidone—Weight decreased—Levothyroxine—hypothyroidism	0.00854	0.0152	CcSEcCtD
Iloperidone—Weight decreased—Dextrothyroxine—hypothyroidism	0.00854	0.0152	CcSEcCtD
Iloperidone—Cardiac failure—Liotrix—hypothyroidism	0.00823	0.0147	CcSEcCtD
Iloperidone—DRD4—testis—hypothyroidism	0.00808	0.0225	CbGeAlD
Iloperidone—Affect lability—Liotrix—hypothyroidism	0.0079	0.0141	CcSEcCtD
Iloperidone—Mood swings—Liotrix—hypothyroidism	0.00761	0.0136	CcSEcCtD
Iloperidone—Dehydration—Liotrix—hypothyroidism	0.00747	0.0133	CcSEcCtD
Iloperidone—Hypokalaemia—Liotrix—hypothyroidism	0.00731	0.013	CcSEcCtD
Iloperidone—HTR2A—nerve—hypothyroidism	0.00692	0.0192	CbGeAlD
Iloperidone—Arrhythmia—Levothyroxine—hypothyroidism	0.00675	0.012	CcSEcCtD
Iloperidone—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00675	0.012	CcSEcCtD
Iloperidone—Weight decreased—Liotrix—hypothyroidism	0.00628	0.0112	CcSEcCtD
Iloperidone—Tremor—Dextrothyroxine—hypothyroidism	0.00616	0.011	CcSEcCtD
Iloperidone—Tremor—Levothyroxine—hypothyroidism	0.00616	0.011	CcSEcCtD
Iloperidone—Agitation—Levothyroxine—hypothyroidism	0.00604	0.0108	CcSEcCtD
Iloperidone—Agitation—Dextrothyroxine—hypothyroidism	0.00604	0.0108	CcSEcCtD
Iloperidone—Palpitations—Dextrothyroxine—hypothyroidism	0.00581	0.0104	CcSEcCtD
Iloperidone—Palpitations—Levothyroxine—hypothyroidism	0.00581	0.0104	CcSEcCtD
Iloperidone—Arthralgia—Dextrothyroxine—hypothyroidism	0.0056	0.00999	CcSEcCtD
Iloperidone—Arthralgia—Levothyroxine—hypothyroidism	0.0056	0.00999	CcSEcCtD
Iloperidone—Confusional state—Levothyroxine—hypothyroidism	0.00541	0.00966	CcSEcCtD
Iloperidone—Confusional state—Dextrothyroxine—hypothyroidism	0.00541	0.00966	CcSEcCtD
Iloperidone—CYP3A7—liver—hypothyroidism	0.00525	0.0146	CbGeAlD
Iloperidone—Tachycardia—Levothyroxine—hypothyroidism	0.00524	0.00935	CcSEcCtD
Iloperidone—Tachycardia—Dextrothyroxine—hypothyroidism	0.00524	0.00935	CcSEcCtD
Iloperidone—SIGMAR1—adrenal cortex—hypothyroidism	0.00498	0.0139	CbGeAlD
Iloperidone—Arrhythmia—Liotrix—hypothyroidism	0.00496	0.00886	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00489	0.00873	CcSEcCtD
Iloperidone—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00489	0.00873	CcSEcCtD
Iloperidone—HTR1D—cardiovascular system—hypothyroidism	0.00488	0.0136	CbGeAlD
Iloperidone—SIGMAR1—heart—hypothyroidism	0.00482	0.0134	CbGeAlD
Iloperidone—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00478	0.00854	CcSEcCtD
Iloperidone—Dyspnoea—Levothyroxine—hypothyroidism	0.00478	0.00854	CcSEcCtD
Iloperidone—Fatigue—Levothyroxine—hypothyroidism	0.00463	0.00826	CcSEcCtD
Iloperidone—Fatigue—Dextrothyroxine—hypothyroidism	0.00463	0.00826	CcSEcCtD
Iloperidone—Vision blurred—Liotrix—hypothyroidism	0.00456	0.00814	CcSEcCtD
Iloperidone—Tremor—Liotrix—hypothyroidism	0.00453	0.00809	CcSEcCtD
Iloperidone—CYP3A7-CYP3A51P—liver—hypothyroidism	0.00447	0.0124	CbGeAlD
Iloperidone—Agitation—Liotrix—hypothyroidism	0.00444	0.00793	CcSEcCtD
Iloperidone—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00442	0.00789	CcSEcCtD
Iloperidone—Feeling abnormal—Levothyroxine—hypothyroidism	0.00442	0.00789	CcSEcCtD
Iloperidone—Palpitations—Liotrix—hypothyroidism	0.00427	0.00763	CcSEcCtD
Iloperidone—Body temperature increased—Levothyroxine—hypothyroidism	0.00424	0.00757	CcSEcCtD
Iloperidone—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00424	0.00757	CcSEcCtD
Iloperidone—HTR7—heart—hypothyroidism	0.00412	0.0115	CbGeAlD
Iloperidone—Arthralgia—Liotrix—hypothyroidism	0.00412	0.00735	CcSEcCtD
Iloperidone—HTR1A—cardiovascular system—hypothyroidism	0.00407	0.0113	CbGeAlD
Iloperidone—SIGMAR1—pituitary gland—hypothyroidism	0.00403	0.0112	CbGeAlD
Iloperidone—Confusional state—Liotrix—hypothyroidism	0.00398	0.0071	CcSEcCtD
Iloperidone—ADRA1A—heart—hypothyroidism	0.00397	0.011	CbGeAlD
Iloperidone—Oedema—Liotrix—hypothyroidism	0.00395	0.00705	CcSEcCtD
Iloperidone—Infection—Liotrix—hypothyroidism	0.00392	0.007	CcSEcCtD
Iloperidone—ADRA2C—adrenal cortex—hypothyroidism	0.00391	0.0109	CbGeAlD
Iloperidone—HTR7—cardiovascular system—hypothyroidism	0.00389	0.0108	CbGeAlD
Iloperidone—Tachycardia—Liotrix—hypothyroidism	0.00385	0.00688	CcSEcCtD
Iloperidone—Asthenia—Levothyroxine—hypothyroidism	0.00385	0.00687	CcSEcCtD
Iloperidone—Asthenia—Dextrothyroxine—hypothyroidism	0.00385	0.00687	CcSEcCtD
Iloperidone—ADRA2C—heart—hypothyroidism	0.00379	0.0105	CbGeAlD
Iloperidone—ADRA1A—cardiovascular system—hypothyroidism	0.00375	0.0104	CbGeAlD
Iloperidone—Hypotension—Liotrix—hypothyroidism	0.00369	0.00658	CcSEcCtD
Iloperidone—Diarrhoea—Levothyroxine—hypothyroidism	0.00367	0.00655	CcSEcCtD
Iloperidone—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00367	0.00655	CcSEcCtD
Iloperidone—SIGMAR1—adrenal gland—hypothyroidism	0.0036	0.01	CbGeAlD
Iloperidone—SIGMAR1—blood—hypothyroidism	0.0036	0.01	CbGeAlD
Iloperidone—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.0036	0.00642	CcSEcCtD
Iloperidone—Paraesthesia—Liotrix—hypothyroidism	0.00354	0.00633	CcSEcCtD
Iloperidone—HTR7—gonad—hypothyroidism	0.00353	0.00981	CbGeAlD
Iloperidone—Dyspnoea—Liotrix—hypothyroidism	0.00352	0.00628	CcSEcCtD
Iloperidone—SIGMAR1—thyroid gland—hypothyroidism	0.00347	0.00965	CbGeAlD
Iloperidone—Fatigue—Liotrix—hypothyroidism	0.0034	0.00607	CcSEcCtD
Iloperidone—Rash—Dextrothyroxine—hypothyroidism	0.00338	0.00604	CcSEcCtD
Iloperidone—Rash—Levothyroxine—hypothyroidism	0.00338	0.00604	CcSEcCtD
Iloperidone—Dermatitis—Dextrothyroxine—hypothyroidism	0.00338	0.00603	CcSEcCtD
Iloperidone—Dermatitis—Levothyroxine—hypothyroidism	0.00338	0.00603	CcSEcCtD
Iloperidone—SIGMAR1—female gonad—hypothyroidism	0.00335	0.00933	CbGeAlD
Iloperidone—DRD2—pituitary gland—hypothyroidism	0.00325	0.00905	CbGeAlD
Iloperidone—Feeling abnormal—Liotrix—hypothyroidism	0.00325	0.00581	CcSEcCtD
Iloperidone—HTR1A—adrenal gland—hypothyroidism	0.00322	0.00894	CbGeAlD
Iloperidone—Nausea—Levothyroxine—hypothyroidism	0.00319	0.00569	CcSEcCtD
Iloperidone—Nausea—Dextrothyroxine—hypothyroidism	0.00319	0.00569	CcSEcCtD
Iloperidone—ADRA2C—pituitary gland—hypothyroidism	0.00316	0.00879	CbGeAlD
Iloperidone—Body temperature increased—Liotrix—hypothyroidism	0.00312	0.00557	CcSEcCtD
Iloperidone—HTR7—adrenal gland—hypothyroidism	0.00307	0.00855	CbGeAlD
Iloperidone—HTR7—blood—hypothyroidism	0.00307	0.00854	CbGeAlD
Iloperidone—ADRA2A—heart—hypothyroidism	0.00302	0.0084	CbGeAlD
Iloperidone—SIGMAR1—testis—hypothyroidism	0.00298	0.00827	CbGeAlD
Iloperidone—ADRA1A—adrenal gland—hypothyroidism	0.00297	0.00824	CbGeAlD
Iloperidone—ADRA1A—blood—hypothyroidism	0.00296	0.00824	CbGeAlD
Iloperidone—Asthenia—Liotrix—hypothyroidism	0.00283	0.00506	CcSEcCtD
Iloperidone—ADRA2C—adrenal gland—hypothyroidism	0.00283	0.00786	CbGeAlD
Iloperidone—ADRA2C—blood—hypothyroidism	0.00282	0.00785	CbGeAlD
Iloperidone—SIGMAR1—liver—hypothyroidism	0.00281	0.00782	CbGeAlD
Iloperidone—CYP2E1—cardiovascular system—hypothyroidism	0.00279	0.00775	CbGeAlD
Iloperidone—SIGMAR1—cerebellum—hypothyroidism	0.00275	0.00764	CbGeAlD
Iloperidone—Diarrhoea—Liotrix—hypothyroidism	0.0027	0.00482	CcSEcCtD
Iloperidone—ADRA2C—female gonad—hypothyroidism	0.00263	0.00732	CbGeAlD
Iloperidone—Dizziness—Liotrix—hypothyroidism	0.00261	0.00466	CcSEcCtD
Iloperidone—ADRA2A—gonad—hypothyroidism	0.00259	0.00719	CbGeAlD
Iloperidone—HTR2A—heart—hypothyroidism	0.00257	0.00714	CbGeAlD
Iloperidone—HTR7—testis—hypothyroidism	0.00254	0.00707	CbGeAlD
Iloperidone—ADRA2A—pituitary gland—hypothyroidism	0.00252	0.00702	CbGeAlD
Iloperidone—Rash—Liotrix—hypothyroidism	0.00249	0.00444	CcSEcCtD
Iloperidone—Dermatitis—Liotrix—hypothyroidism	0.00249	0.00444	CcSEcCtD
Iloperidone—HTR1A—cerebellum—hypothyroidism	0.00246	0.00683	CbGeAlD
Iloperidone—CYP1A2—blood—hypothyroidism	0.00245	0.00682	CbGeAlD
Iloperidone—HTR2A—cardiovascular system—hypothyroidism	0.00242	0.00674	CbGeAlD
Iloperidone—DRD2—testis—hypothyroidism	0.0024	0.00668	CbGeAlD
Iloperidone—HTR7—liver—hypothyroidism	0.0024	0.00668	CbGeAlD
Iloperidone—CYP1A2—thyroid gland—hypothyroidism	0.00237	0.00658	CbGeAlD
Iloperidone—CYP3A5—blood—hypothyroidism	0.00236	0.00657	CbGeAlD
Iloperidone—HTR7—cerebellum—hypothyroidism	0.00235	0.00653	CbGeAlD
Iloperidone—Nausea—Liotrix—hypothyroidism	0.00234	0.00419	CcSEcCtD
Iloperidone—ADRA2C—testis—hypothyroidism	0.00234	0.0065	CbGeAlD
Iloperidone—ADRA1A—liver—hypothyroidism	0.00232	0.00645	CbGeAlD
Iloperidone—HRH1—adrenal gland—hypothyroidism	0.0023	0.00638	CbGeAlD
Iloperidone—ADRA1A—cerebellum—hypothyroidism	0.00226	0.0063	CbGeAlD
Iloperidone—ADRA2A—adrenal gland—hypothyroidism	0.00225	0.00627	CbGeAlD
Iloperidone—ADRA2A—blood—hypothyroidism	0.00225	0.00627	CbGeAlD
Iloperidone—DRD2—cerebellum—hypothyroidism	0.00222	0.00617	CbGeAlD
Iloperidone—ADRA2C—liver—hypothyroidism	0.00221	0.00614	CbGeAlD
Iloperidone—CYP2E1—adrenal gland—hypothyroidism	0.00221	0.00613	CbGeAlD
Iloperidone—CYP2E1—blood—hypothyroidism	0.00221	0.00613	CbGeAlD
Iloperidone—CYP3A5—female gonad—hypothyroidism	0.0022	0.00613	CbGeAlD
Iloperidone—HTR2A—gonad—hypothyroidism	0.0022	0.00612	CbGeAlD
Iloperidone—ADRA2A—thyroid gland—hypothyroidism	0.00218	0.00605	CbGeAlD
Iloperidone—ADRA2C—cerebellum—hypothyroidism	0.00216	0.006	CbGeAlD
Iloperidone—HTR2A—pituitary gland—hypothyroidism	0.00215	0.00597	CbGeAlD
Iloperidone—HRH1—female gonad—hypothyroidism	0.00214	0.00595	CbGeAlD
Iloperidone—CYP2E1—thyroid gland—hypothyroidism	0.00213	0.00592	CbGeAlD
Iloperidone—ADRA2A—female gonad—hypothyroidism	0.0021	0.00584	CbGeAlD
Iloperidone—HTR2A—adrenal gland—hypothyroidism	0.00192	0.00533	CbGeAlD
Iloperidone—CYP1A2—liver—hypothyroidism	0.00192	0.00533	CbGeAlD
Iloperidone—HTR2A—blood—hypothyroidism	0.00192	0.00533	CbGeAlD
Iloperidone—HRH1—testis—hypothyroidism	0.0019	0.00528	CbGeAlD
Iloperidone—ADRA2A—testis—hypothyroidism	0.00186	0.00518	CbGeAlD
Iloperidone—CYP3A5—liver—hypothyroidism	0.00185	0.00514	CbGeAlD
Iloperidone—CYP2E1—testis—hypothyroidism	0.00182	0.00507	CbGeAlD
Iloperidone—CYP3A4—blood—hypothyroidism	0.00177	0.00493	CbGeAlD
Iloperidone—CYP2D6—blood—hypothyroidism	0.00175	0.00485	CbGeAlD
Iloperidone—CYP2E1—liver—hypothyroidism	0.00172	0.00479	CbGeAlD
Iloperidone—ADRA2A—cerebellum—hypothyroidism	0.00172	0.00479	CbGeAlD
Iloperidone—CYP2E1—cerebellum—hypothyroidism	0.00168	0.00468	CbGeAlD
Iloperidone—CYP2D6—female gonad—hypothyroidism	0.00163	0.00453	CbGeAlD
Iloperidone—HTR2A—testis—hypothyroidism	0.00159	0.00441	CbGeAlD
Iloperidone—HTR2A—liver—hypothyroidism	0.0015	0.00417	CbGeAlD
Iloperidone—HTR2A—cerebellum—hypothyroidism	0.00146	0.00407	CbGeAlD
Iloperidone—CYP2D6—testis—hypothyroidism	0.00144	0.00402	CbGeAlD
Iloperidone—CYP3A4—liver—hypothyroidism	0.00139	0.00386	CbGeAlD
Iloperidone—CYP2D6—liver—hypothyroidism	0.00137	0.0038	CbGeAlD
Iloperidone—CYP2D6—cerebellum—hypothyroidism	0.00133	0.00371	CbGeAlD
Iloperidone—DRD4—Signaling by GPCR—VAV3—hypothyroidism	8.17e-05	0.00102	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—AVP—hypothyroidism	8.17e-05	0.00102	CbGpPWpGaD
Iloperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	8.14e-05	0.00101	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	8.13e-05	0.00101	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	8.13e-05	0.00101	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—VAV3—hypothyroidism	8.1e-05	0.00101	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—TPO—hypothyroidism	8.08e-05	0.00101	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—VAV3—hypothyroidism	7.99e-05	0.000996	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TRH—hypothyroidism	7.97e-05	0.000993	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—CLTC—hypothyroidism	7.93e-05	0.000988	CbGpPWpGaD
Iloperidone—HTR1A—GPCR ligand binding—POMC—hypothyroidism	7.89e-05	0.000983	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TSHB—hypothyroidism	7.89e-05	0.000983	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—TSHR—hypothyroidism	7.89e-05	0.000983	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—CLTC—hypothyroidism	7.89e-05	0.000983	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—AVP—hypothyroidism	7.87e-05	0.000981	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TRH—hypothyroidism	7.86e-05	0.00098	CbGpPWpGaD
Iloperidone—HTR2C—GPCR ligand binding—POMC—hypothyroidism	7.85e-05	0.000978	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—AVP—hypothyroidism	7.8e-05	0.000972	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—AVP—hypothyroidism	7.7e-05	0.000959	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—CLTC—hypothyroidism	7.67e-05	0.000956	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR ligand binding—POMC—hypothyroidism	7.63e-05	0.000951	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—VAV3—hypothyroidism	7.35e-05	0.000916	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—SH2B3—hypothyroidism	7.35e-05	0.000916	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—SH2B3—hypothyroidism	7.35e-05	0.000915	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—SH2B3—hypothyroidism	7.3e-05	0.000909	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—ATP5O—hypothyroidism	7.28e-05	0.000907	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—TSHB—hypothyroidism	7.28e-05	0.000907	CbGpPWpGaD
Iloperidone—CYP1A2—Biological oxidations—POMC—hypothyroidism	7.26e-05	0.000904	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—VAV3—hypothyroidism	7.26e-05	0.000904	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TSHR—hypothyroidism	7.1e-05	0.000885	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—TSHB—hypothyroidism	7.1e-05	0.000885	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—AVP—hypothyroidism	7.09e-05	0.000883	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—TSHB—hypothyroidism	7.07e-05	0.000881	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—SH2B3—hypothyroidism	7.03e-05	0.000876	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TSHB—hypothyroidism	7.01e-05	0.000873	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—TSHR—hypothyroidism	7.01e-05	0.000873	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—AVP—hypothyroidism	6.99e-05	0.000871	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—VAV3—hypothyroidism	6.96e-05	0.000868	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—CLTC—hypothyroidism	6.96e-05	0.000867	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	6.93e-05	0.000863	CbGpPWpGaD
Iloperidone—DRD2—GPCR ligand binding—POMC—hypothyroidism	6.93e-05	0.000863	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TRH—hypothyroidism	6.85e-05	0.000854	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—CLTC—hypothyroidism	6.85e-05	0.000854	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—TPO—hypothyroidism	6.84e-05	0.000853	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—CLTC—hypothyroidism	6.83e-05	0.000852	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TRH—hypothyroidism	6.82e-05	0.000849	CbGpPWpGaD
Iloperidone—HTR2A—GPCR ligand binding—POMC—hypothyroidism	6.82e-05	0.000849	CbGpPWpGaD
Iloperidone—HRH1—GPCR ligand binding—POMC—hypothyroidism	6.8e-05	0.000848	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—VAV3—hypothyroidism	6.74e-05	0.00084	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—AVP—hypothyroidism	6.71e-05	0.000836	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	6.71e-05	0.000836	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	6.68e-05	0.000832	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	6.67e-05	0.000832	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TRH—hypothyroidism	6.63e-05	0.000826	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—IYD—hypothyroidism	6.61e-05	0.000823	CbGpPWpGaD
Iloperidone—ADRA2C—Hemostasis—IGF1—hypothyroidism	6.57e-05	0.000818	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—AVP—hypothyroidism	6.49e-05	0.000809	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	6.49e-05	0.000808	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	6.34e-05	0.00079	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—SH2B3—hypothyroidism	6.33e-05	0.000789	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—VAV3—hypothyroidism	6.32e-05	0.000788	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—PIK3C2A—hypothyroidism	6.3e-05	0.000785	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	6.29e-05	0.000784	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—SH2B3—hypothyroidism	6.25e-05	0.000778	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	6.23e-05	0.000777	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	6.2e-05	0.000773	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—VAV3—hypothyroidism	6.12e-05	0.000763	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	6.11e-05	0.000762	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TSHB—hypothyroidism	6.11e-05	0.000761	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—TSHR—hypothyroidism	6.11e-05	0.000761	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—AVP—hypothyroidism	6.09e-05	0.000759	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TSHB—hypothyroidism	6.08e-05	0.000757	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—TSHR—hypothyroidism	6.08e-05	0.000757	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—AVP—hypothyroidism	6.06e-05	0.000755	CbGpPWpGaD
Iloperidone—HTR6—GPCR downstream signaling—POMC—hypothyroidism	6.02e-05	0.000751	CbGpPWpGaD
Iloperidone—HTR7—GPCR downstream signaling—POMC—hypothyroidism	6.02e-05	0.00075	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—VAV3—hypothyroidism	6.02e-05	0.00075	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TRH—hypothyroidism	6.02e-05	0.00075	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—VAV3—hypothyroidism	6e-05	0.000748	CbGpPWpGaD
Iloperidone—HTR1D—GPCR downstream signaling—POMC—hypothyroidism	5.98e-05	0.000745	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TRH—hypothyroidism	5.92e-05	0.000738	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TSHB—hypothyroidism	5.91e-05	0.000736	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—TSHR—hypothyroidism	5.91e-05	0.000736	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TRH—hypothyroidism	5.91e-05	0.000736	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—AVP—hypothyroidism	5.9e-05	0.000735	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—AVP—hypothyroidism	5.89e-05	0.000734	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	5.89e-05	0.000734	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—AVP—hypothyroidism	5.8e-05	0.000722	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TRH—hypothyroidism	5.8e-05	0.000722	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—AVP—hypothyroidism	5.78e-05	0.000721	CbGpPWpGaD
Iloperidone—DRD4—GPCR downstream signaling—POMC—hypothyroidism	5.76e-05	0.000718	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—TSHB—hypothyroidism	5.74e-05	0.000715	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	5.68e-05	0.000707	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—ATP5O—hypothyroidism	5.62e-05	0.0007	CbGpPWpGaD
Iloperidone—CYP3A4—Biological oxidations—POMC—hypothyroidism	5.6e-05	0.000698	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—VAV3—hypothyroidism	5.55e-05	0.000692	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	5.47e-05	0.000682	CbGpPWpGaD
Iloperidone—HTR6—Signaling by GPCR—POMC—hypothyroidism	5.47e-05	0.000682	CbGpPWpGaD
Iloperidone—HTR7—Signaling by GPCR—POMC—hypothyroidism	5.46e-05	0.000681	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—VAV3—hypothyroidism	5.46e-05	0.000681	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—PRL—hypothyroidism	5.46e-05	0.00068	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—VAV3—hypothyroidism	5.45e-05	0.000679	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—PRL—hypothyroidism	5.45e-05	0.000679	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—SLC5A5—hypothyroidism	5.45e-05	0.000679	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—SH2B3—hypothyroidism	5.44e-05	0.000678	CbGpPWpGaD
Iloperidone—HTR1D—Signaling by GPCR—POMC—hypothyroidism	5.43e-05	0.000676	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	5.42e-05	0.000675	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—PRL—hypothyroidism	5.41e-05	0.000675	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TRH—hypothyroidism	5.39e-05	0.000671	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TSHB—hypothyroidism	5.36e-05	0.000668	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—TSHR—hypothyroidism	5.36e-05	0.000668	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—AVP—hypothyroidism	5.35e-05	0.000667	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	5.35e-05	0.000667	CbGpPWpGaD
Iloperidone—ADRA2A—Hemostasis—IGF1—hypothyroidism	5.33e-05	0.000665	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—SLC5A5—hypothyroidism	5.29e-05	0.000659	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—TPO—hypothyroidism	5.28e-05	0.000658	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TSHR—hypothyroidism	5.28e-05	0.000657	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—TSHB—hypothyroidism	5.28e-05	0.000657	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	5.27e-05	0.000657	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—TSHB—hypothyroidism	5.27e-05	0.000657	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	5.27e-05	0.000656	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TSHR—hypothyroidism	5.26e-05	0.000656	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—TSHB—hypothyroidism	5.26e-05	0.000656	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—AVP—hypothyroidism	5.26e-05	0.000656	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—TSHB—hypothyroidism	5.26e-05	0.000656	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—AVP—hypothyroidism	5.25e-05	0.000655	CbGpPWpGaD
Iloperidone—DRD4—Signaling by GPCR—POMC—hypothyroidism	5.23e-05	0.000652	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—PRL—hypothyroidism	5.22e-05	0.00065	CbGpPWpGaD
Iloperidone—DRD1—GPCR downstream signaling—POMC—hypothyroidism	5.19e-05	0.000646	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	5.17e-05	0.000644	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	5.17e-05	0.000644	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	5.15e-05	0.000642	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	5.12e-05	0.000638	CbGpPWpGaD
Iloperidone—DRD3—GPCR downstream signaling—POMC—hypothyroidism	5.12e-05	0.000638	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—VAV3—hypothyroidism	5.05e-05	0.000629	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—VAV3—hypothyroidism	5.04e-05	0.000628	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—VAV3—hypothyroidism	5.01e-05	0.000624	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	4.97e-05	0.000619	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—AVP—hypothyroidism	4.86e-05	0.000606	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—AVP—hypothyroidism	4.86e-05	0.000605	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—VAV3—hypothyroidism	4.83e-05	0.000601	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—AVP—hypothyroidism	4.83e-05	0.000601	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	4.8e-05	0.000598	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	4.8e-05	0.000598	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	4.79e-05	0.000597	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—SH2B3—hypothyroidism	4.78e-05	0.000596	CbGpPWpGaD
Iloperidone—DRD1—Signaling by GPCR—POMC—hypothyroidism	4.71e-05	0.000587	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—SH2B3—hypothyroidism	4.7e-05	0.000586	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—PIK3C2A—hypothyroidism	4.7e-05	0.000585	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—PRL—hypothyroidism	4.7e-05	0.000585	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—SH2B3—hypothyroidism	4.69e-05	0.000585	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	4.69e-05	0.000584	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—AVP—hypothyroidism	4.65e-05	0.000579	CbGpPWpGaD
Iloperidone—DRD3—Signaling by GPCR—POMC—hypothyroidism	4.65e-05	0.000579	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—PRL—hypothyroidism	4.63e-05	0.000577	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	4.6e-05	0.000574	CbGpPWpGaD
Iloperidone—HTR1A—GPCR downstream signaling—POMC—hypothyroidism	4.46e-05	0.000556	CbGpPWpGaD
Iloperidone—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	4.44e-05	0.000553	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—VAV3—hypothyroidism	4.34e-05	0.000541	CbGpPWpGaD
Iloperidone—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	4.31e-05	0.000538	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—SLC5A5—hypothyroidism	4.3e-05	0.000536	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—VAV3—hypothyroidism	4.29e-05	0.000534	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	4.28e-05	0.000533	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—AVP—hypothyroidism	4.19e-05	0.000522	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—AVP—hypothyroidism	4.13e-05	0.000515	CbGpPWpGaD
Iloperidone—HTR1A—Signaling by GPCR—POMC—hypothyroidism	4.05e-05	0.000505	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—PRL—hypothyroidism	4.04e-05	0.000503	CbGpPWpGaD
Iloperidone—HTR2C—Signaling by GPCR—POMC—hypothyroidism	4.03e-05	0.000502	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—PRL—hypothyroidism	4.02e-05	0.000501	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—SLC5A5—hypothyroidism	3.95e-05	0.000492	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—SLC5A5—hypothyroidism	3.94e-05	0.000491	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	3.92e-05	0.000488	CbGpPWpGaD
Iloperidone—DRD2—GPCR downstream signaling—POMC—hypothyroidism	3.91e-05	0.000488	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—PRL—hypothyroidism	3.91e-05	0.000487	CbGpPWpGaD
Iloperidone—HTR2A—GPCR downstream signaling—POMC—hypothyroidism	3.85e-05	0.00048	CbGpPWpGaD
Iloperidone—HRH1—GPCR downstream signaling—POMC—hypothyroidism	3.84e-05	0.000479	CbGpPWpGaD
Iloperidone—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	3.77e-05	0.00047	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—TSHB—hypothyroidism	3.74e-05	0.000466	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—VAV3—hypothyroidism	3.74e-05	0.000466	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—VAV3—hypothyroidism	3.72e-05	0.000463	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	3.62e-05	0.00045	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—AVP—hypothyroidism	3.6e-05	0.000449	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—AVP—hypothyroidism	3.58e-05	0.000446	CbGpPWpGaD
Iloperidone—DRD2—Signaling by GPCR—POMC—hypothyroidism	3.56e-05	0.000443	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—PRL—hypothyroidism	3.55e-05	0.000442	CbGpPWpGaD
Iloperidone—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	3.5e-05	0.000437	CbGpPWpGaD
Iloperidone—HTR2A—Signaling by GPCR—POMC—hypothyroidism	3.5e-05	0.000436	CbGpPWpGaD
Iloperidone—HRH1—Signaling by GPCR—POMC—hypothyroidism	3.49e-05	0.000435	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—PRL—hypothyroidism	3.49e-05	0.000435	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—AVP—hypothyroidism	3.48e-05	0.000434	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—PRL—hypothyroidism	3.48e-05	0.000434	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	3.43e-05	0.000427	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—PRL—hypothyroidism	3.42e-05	0.000426	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	3.33e-05	0.000415	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—VAV3—hypothyroidism	3.28e-05	0.000409	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—POMC—hypothyroidism	3.23e-05	0.000403	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—POMC—hypothyroidism	3.23e-05	0.000402	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—VAV3—hypothyroidism	3.23e-05	0.000402	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—VAV3—hypothyroidism	3.22e-05	0.000401	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—POMC—hypothyroidism	3.21e-05	0.0004	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	3.18e-05	0.000397	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—PRL—hypothyroidism	3.17e-05	0.000396	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—TSHB—hypothyroidism	3.17e-05	0.000395	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—AVP—hypothyroidism	3.16e-05	0.000394	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	3.16e-05	0.000394	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—AVP—hypothyroidism	3.11e-05	0.000388	CbGpPWpGaD
Iloperidone—HTR6—Signaling Pathways—IGF1—hypothyroidism	3.11e-05	0.000387	CbGpPWpGaD
Iloperidone—HTR7—Signaling Pathways—IGF1—hypothyroidism	3.1e-05	0.000387	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—AVP—hypothyroidism	3.1e-05	0.000387	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—POMC—hypothyroidism	3.09e-05	0.000385	CbGpPWpGaD
Iloperidone—HTR1D—Signaling Pathways—IGF1—hypothyroidism	3.08e-05	0.000384	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—AVP—hypothyroidism	3.04e-05	0.000379	CbGpPWpGaD
Iloperidone—DRD4—Signaling Pathways—IGF1—hypothyroidism	2.97e-05	0.00037	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	2.94e-05	0.000366	CbGpPWpGaD
Iloperidone—CYP3A7—Metabolism—POMC—hypothyroidism	2.85e-05	0.000355	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—AVP—hypothyroidism	2.83e-05	0.000353	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	2.82e-05	0.000352	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—SLC5A5—hypothyroidism	2.8e-05	0.000349	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.79e-05	0.000347	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—POMC—hypothyroidism	2.78e-05	0.000347	CbGpPWpGaD
Iloperidone—ADRA2C—Metabolism—POMC—hypothyroidism	2.77e-05	0.000345	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—POMC—hypothyroidism	2.74e-05	0.000342	CbGpPWpGaD
Iloperidone—DRD1—Signaling Pathways—IGF1—hypothyroidism	2.68e-05	0.000333	CbGpPWpGaD
Iloperidone—DRD3—Signaling Pathways—IGF1—hypothyroidism	2.64e-05	0.000329	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—TSHB—hypothyroidism	2.45e-05	0.000305	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—POMC—hypothyroidism	2.39e-05	0.000298	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—POMC—hypothyroidism	2.38e-05	0.000297	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—SLC5A5—hypothyroidism	2.37e-05	0.000296	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—POMC—hypothyroidism	2.31e-05	0.000288	CbGpPWpGaD
Iloperidone—HTR1A—Signaling Pathways—IGF1—hypothyroidism	2.3e-05	0.000287	CbGpPWpGaD
Iloperidone—HTR2C—Signaling Pathways—IGF1—hypothyroidism	2.29e-05	0.000285	CbGpPWpGaD
Iloperidone—ADRA2A—Metabolism—POMC—hypothyroidism	2.25e-05	0.00028	CbGpPWpGaD
Iloperidone—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	2.23e-05	0.000277	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.18e-05	0.000272	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—POMC—hypothyroidism	2.1e-05	0.000262	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—POMC—hypothyroidism	2.07e-05	0.000258	CbGpPWpGaD
Iloperidone—CYP2E1—Metabolism—POMC—hypothyroidism	2.06e-05	0.000257	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—POMC—hypothyroidism	2.06e-05	0.000257	CbGpPWpGaD
Iloperidone—CYP3A5—Metabolism—POMC—hypothyroidism	2.06e-05	0.000257	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—POMC—hypothyroidism	2.02e-05	0.000252	CbGpPWpGaD
Iloperidone—DRD2—Signaling Pathways—IGF1—hypothyroidism	2.02e-05	0.000252	CbGpPWpGaD
Iloperidone—HTR2A—Signaling Pathways—IGF1—hypothyroidism	1.99e-05	0.000248	CbGpPWpGaD
Iloperidone—HRH1—Signaling Pathways—IGF1—hypothyroidism	1.98e-05	0.000247	CbGpPWpGaD
Iloperidone—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	1.95e-05	0.000243	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—POMC—hypothyroidism	1.88e-05	0.000234	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.83e-05	0.000228	CbGpPWpGaD
Iloperidone—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	1.81e-05	0.000225	CbGpPWpGaD
Iloperidone—CYP2D6—Metabolism—POMC—hypothyroidism	1.47e-05	0.000183	CbGpPWpGaD
Iloperidone—CYP1A2—Metabolism—POMC—hypothyroidism	1.24e-05	0.000155	CbGpPWpGaD
Iloperidone—CYP3A4—Metabolism—POMC—hypothyroidism	9.58e-06	0.000119	CbGpPWpGaD
